Ac­cel­er­at­ed ap­proval in­com­ing? Mod­er­na 'hope­ful' for per­son­al­ized can­cer vac­cine

Mod­er­na will look to use the FDA’s ac­cel­er­at­ed ap­proval path­way for its per­son­al­ized can­cer vac­cine, pres­i­dent Stephen Hoge said at Cowen’s an­nu­al con­fer­ence on health­care …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER